Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finkel

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Progress in Clinical and Biological Research|January 1, 1983
Orphan products: definition and activitiesM J Finkel
Clinical Pharmacology and Therapeutics|October 13, 2017
The relationships of the American Society for Clinical Pharmacology and Therapeutics to governmentMarion J Finkel
Lipids|January 1, 1977
FDA considerations regarding new hypolipidemic agentsM J Finkel
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Important considerations for the clinical evaluation of drugs: appropriate dosing regimensM J Finkel
Connecticut Medicine|April 1, 1976
From cathartics to catharsis: psychology's emergence from medicineN J Finkel
Advances in Experimental Medicine and Biology|January 1, 1972
Antilipemic drugs and the position of the FDAM J Finkel
Clinical Pharmacology and Therapeutics|February 1, 1990
The relationships of the American Society for Clinical Pharmacology and Therapeutics to governmentM J Finkel
JAMA|May 10, 1971
Measles, a renewed challengeA J Finkel
The New England Journal of Medicine|October 7, 1982
The development of orphan productsM J Finkel
Medicine and Law|January 1, 1992
Insanity: making law in the absence of evidenceN J Finkel
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Progress in Clinical and Biological Research|January 1, 1983
Orphan products: definition and activitiesM J Finkel
Clinical Pharmacology and Therapeutics|October 13, 2017
The relationships of the American Society for Clinical Pharmacology and Therapeutics to governmentMarion J Finkel
Lipids|January 1, 1977
FDA considerations regarding new hypolipidemic agentsM J Finkel
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Important considerations for the clinical evaluation of drugs: appropriate dosing regimensM J Finkel
Connecticut Medicine|April 1, 1976
From cathartics to catharsis: psychology's emergence from medicineN J Finkel
Advances in Experimental Medicine and Biology|January 1, 1972
Antilipemic drugs and the position of the FDAM J Finkel
Clinical Pharmacology and Therapeutics|February 1, 1990
The relationships of the American Society for Clinical Pharmacology and Therapeutics to governmentM J Finkel
JAMA|May 10, 1971
Measles, a renewed challengeA J Finkel
The New England Journal of Medicine|October 7, 1982
The development of orphan productsM J Finkel
Medicine and Law|January 1, 1992
Insanity: making law in the absence of evidenceN J Finkel
Pageof 18